DrugRisk Update: Study Shows Internal Bleeding Fatality Rate Higher With Pradaxa Than Warfarin
The DrugRisk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com
Orlando, FL (PRWEB) January 18, 2013
The prescription drug resource center DrugRisk.com is alerting patients taking the blood thinner Pradaxa that new information has been added showing anticoagulants rank among the highest in patient risks, and that patients experiencing internal bleeding from Pradaxa may have a higher risk than with warfarin.
The goal of DrugRisk is to improve patient safety through education of the latest drug warnings, recalls, studies and litigation news. “Among these we find it especially important for patients to know of trends with complications reported to the FDA,” explains DrugRisk representative Ryan Mayer.
Information on DrugRisk shows experts disagree about the safety of Pradaxa and its bleeding risks. While there has been no Pradaxa recall, the FDA recently issued an update that the drug carries the same risks as warfarin.* However, the Americal College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.**
Now, DrugRisk has learned that a review of FDA records by the Institute for Safe Medication Practices shows anticoagulants like Pradaxa are among the highest risk outpatient drugs. Also, hemorrhage cases submitted to the agency show bleeding from Pradaxa was nearly 5 times as likely to result in death than with warfarin.***
The resource center has learned that, due to the number of Pradaxa lawsuits filed so far, cases are being consolidated to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.
Judge David Herndon, who is overseeing the litigation, recently reported that as many as 176 cases have been filed and the parties have turned over more than 10,000 pages of evidence.****
Anyone affected by internal bleeding after taking Pradaxa is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.
For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-recall/side-effects/prweb10337011.htm